| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/08/2008 | CN101279082A Analgesic medicament for curing burn, scald and injure caused by poisonous honey |
| 10/08/2008 | CN101279061A Functional sterilizing-liquid |
| 10/08/2008 | CN101279054A Chinese medicinal composition for treating psoriasis |
| 10/08/2008 | CN101279053A Chinese medicine for curing paint dermatitis |
| 10/08/2008 | CN101279050A Aikang paste |
| 10/08/2008 | CN101279043A Effective anti-cracking cream |
| 10/08/2008 | CN101279042A Whelk-eliminating paste and method of preparing the same |
| 10/08/2008 | CN101279032A External use medicament for curing itch |
| 10/08/2008 | CN101279012A Chinese medicine tea for weight reduction, toxin elimination and beauty treatment and matching Chinese medicinal composition |
| 10/08/2008 | CN101279005A Medicament composition for curing vulva inflammation and vulvar pruritus and method of preparing the same |
| 10/08/2008 | CN101279004A Medicament composition for curing pruritus of skin and method of preparing the same |
| 10/08/2008 | CN101278963A Liquid medicament for curing bedsore |
| 10/08/2008 | CN101278952A Black snake wine for preventing and curing rheumatism and rubella acariasis and preparation method |
| 10/08/2008 | CN101278950A Externally used ointment for curing empyrosis and method of producing the same |
| 10/08/2008 | CN101278948A Biological medical membrane and method of preparing the same |
| 10/08/2008 | CN101278943A Externally-applied medicine for curing psora and preparation method thereof |
| 10/08/2008 | CN101278925A Application of embellin in preparation of medicament for inhibiting angiogenesis |
| 10/08/2008 | CN101278896A Chitosan nano silver gel agent and uses thereof |
| 10/08/2008 | CN101278742A Sweet goods of ass jelly series |
| 10/08/2008 | CN100424182C Methods for detecting and treating the early onset of aging-related conditions |
| 10/08/2008 | CN100423777C Glycoprotein compositions |
| 10/08/2008 | CN100423771C Externally applied lotion for quick hair restoring |
| 10/08/2008 | CN100423760C Preparation of Chinese traditional medicine for removing naevus |
| 10/08/2008 | CN100423750C Dermatosis treating medicine |
| 10/08/2008 | CN100423729C Cleaning agent for treating dermatopathy |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas |
| 10/07/2008 | US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | US7431953 Topical antiallergenic cream containing Asian longhorn beetle wastes; animal extracts |
| 10/07/2008 | CA2435946C Piperidine derivatives as neurokinin 1 antagonists |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 10/07/2008 | CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances |
| 10/07/2008 | CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 10/07/2008 | CA2261263C Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 10/07/2008 | CA2259984C Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 10/07/2008 | CA2250219C Materials and methods for making improved liposome compositions |
| 10/02/2008 | WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117767A1 Therapeutic agent for infectious skin or mucosal disease |
| 10/02/2008 | WO2008117481A1 Skin preparation for external use and food and drink |
| 10/02/2008 | WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | WO2008116959A1 Use of maslinic acid and derivatives thereof for treatment of diseases connected with elastase inhibition, such as neuromas, erythemas, sun and heat burns, and psoriasis |
| 10/02/2008 | WO2008116602A1 Cosmetic preparations designed to reduce unsightly cellulite |
| 10/02/2008 | WO2008093024A3 N-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides derivatives, preparation thereof and their use in therapy |
| 10/02/2008 | WO2008079363A3 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 10/02/2008 | WO2008055049A3 Enzyme inhibition using nanoparticles |
| 10/02/2008 | WO2008032054A3 Composite material comprising a tissue matrix compound and a bioactive glass |
| 10/02/2008 | US20080242855 Process for Producing Flavone C Glycoside Derivatives |
| 10/02/2008 | US20080242731 Delivering a near neutral pH topical anesthetic agent in a mixture into a natural body cavity to cause a rapid onset anesthetic effect without precipitation of the anesthetic; use in uterine area; lidocaine for example |
| 10/02/2008 | US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 10/02/2008 | US20080242701 Antitumor agents; anticancer agents; cytotoxic activity; angiogenesis inhibitor; leukemia; colorectal cancer; administering by mouth |
| 10/02/2008 | US20080242686 Pharmaceutical compositions of lavendustin |
| 10/02/2008 | US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| 10/02/2008 | US20080242669 compounds which mimic the secondary structure of alpha -helix regions of biologically active peptides and proteins; compounds are used to reverse fibrotic conditions |
| 10/02/2008 | US20080242645 Mixture of xanthine compound, plant extract containing polyurethane powder and dimethicone; softness; reduced tackiness |
| 10/02/2008 | US20080242642 Minocycline oral dosage forms for the treatment of acne |
| 10/02/2008 | US20080242641 Controlled release carrier selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, and polyvinylpyrrolidone; improved pharmacokinetics as compared to immediate-release minocycline hydrochloride; side effect reduction |
| 10/02/2008 | US20080242631 Impaired wound healing compositions and treatments |
| 10/02/2008 | US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent |
| 10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 10/02/2008 | US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 10/02/2008 | US20080241285 Topical application; scalp thrice a day; forskolin; solubilized form of labdane diterpenoids and freeze dried liquid endosperm of Cocos nucifera |
| 10/02/2008 | US20080241284 Saw Palmetto, Sperol plant extracts by alcohol, supercritical fluid extraction; prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other diseases related to androgen hyperactivity |
| 10/02/2008 | US20080241272 Composition for Prevention and Treatment of Stretch Mark Comprising Citric Acid, Zinc and Arginine |
| 10/02/2008 | US20080241263 Oral and/or Topical Compositions Comprising Prebiotics and Sterols |
| 10/02/2008 | US20080241249 Cyanoacrylate composite |
| 10/02/2008 | US20080241241 Administering controlled release formulations utilizing slow and fast dissolving carriers; reducing side effects |
| 10/02/2008 | US20080241236 Minocycline oral dosage forms for the treatment of acne |
| 10/02/2008 | US20080241235 Controlled release carrier selected from hydroxypropyl methyl cellulose, hydroxypropyl cellulose, and polyvinylpyrrolidone; improved pharmacokinetics as compared to immediate-release minocycline hydrochloride; side effect reduction |
| 10/02/2008 | US20080241230 Method of Treating Scar Tissue |
| 10/02/2008 | US20080241212 Tyrosine-derived aromatic polyester sheet, film or mat of nanofibers optionally including anesthetics, antiinflammatories, microbiocides, leukotriene inhibitors, or antiscarring, antifibrotic, or antineoplastic agents, and that resists capsular contracture and adherence to the implant |
| 10/02/2008 | US20080241197 Minocycline dosage forms for the treatment of acne |
| 10/02/2008 | US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders |
| 10/02/2008 | US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 10/02/2008 | US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 10/02/2008 | US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders |
| 10/02/2008 | US20080241112 Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media |
| 10/02/2008 | US20080241101 Nutrient broth comprising serine protease inhibitors and cytokine for use propgation of skin basement membrane tissues; regenerative medicine; tissue repair |
| 10/02/2008 | US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits |
| 10/02/2008 | US20080241096 IL-1 family variants |
| 10/02/2008 | US20080241079 Skin Care Products |
| 10/02/2008 | US20080241078 Compositions and methods for treating hair loss using c16-c20 aromatic tetrahydro prostaglandins |
| 10/02/2008 | DE102007014375A1 Oleylphosphocholin Oleylphosphocholine |
| 10/02/2008 | CA2682039A1 Cosmetic preparations designed to reduce unsightly cellulite |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/01/2008 | EP1974720A1 Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides |
| 10/01/2008 | EP1974719A1 Conditioned medium and its uses |
| 10/01/2008 | EP1973610A1 Use of polyunsaturated compounds as whitening agents |
| 10/01/2008 | EP1973560A2 Bovine osteopontin formulations for the improvement of the wound healing process |
| 10/01/2008 | EP1673077B1 Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production |
| 10/01/2008 | EP1363600B1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |